reports
Midland States Bancorp, Inc. Appoints Travis Franklin to Board of Dir...
Midland States Bancorp, Inc. Appoints Travis Franklin to Board of Directors EFFINGHAM, Ill., May 07, 2024 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that its Board of Directors has appointed Travis Franklin to its Board, effective May 7, 2024. Mr. Franklin has been appointed to the Board of Midland States Bank, the Company’s wholly-owned Illinois bank subsidiary. Mr. Franklin currently serves as Executive Vice President and Chief Financial Officer of Heartland Dental, LLC, a leading dental support organization that provides operational support to den...
Aquestive Therapeutics Reports First Quarter 2024 Financial Results an...
Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update Met all endpoints in Phase 3 pivotal study for Anaphylm™ (epinephrine) Sublingual Film in first quarter 2024 when compared to EpiPen® and other injectors used for the treatment of anaphylaxisOn track to complete Anaphylm temperature/pH study in second quarter 2024Received positive feedback from FDA on Anaphylm self-administration and allergen exposure protocols; remains on track to complete both studies in third quarter 2024Continues to target filing an Anaphylm New Drug Application (NDA) with ...
SFL - Invitation to Presentation of Q1 2024 Results
SFL - Invitation to Presentation of Q1 2024 Results SFL Corporation Ltd. ("SFL" or the “Company”) (NYSE: SFL) plans to release its preliminary financial results for the first quarter of 2024 on Tuesday, May 14, 2024. SFL plans to host a conference call and webcast for all stakeholders and interested parties on Tuesday, May 14, 2024, at 10:00 AM (EST) / 4:00 PM (CET). Relevant material will on the same day be available from the Investor Relations section of the Company’s website at In order to listen to the conference call and presentation, you may do one of the following: A: Join Confere...
MediaAlpha Announces Launch of Secondary Offering
MediaAlpha Announces Launch of Secondary Offering LOS ANGELES, May 07, 2024 (GLOBE NEWSWIRE) -- MediaAlpha, Inc. (“MediaAlpha”) (NYSE: MAX) today announced the launch of an underwritten secondary public offering of 6,000,000 shares of its Class A common stock by certain selling stockholders (the “Selling Stockholders”). The Selling Stockholders have granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of Class A common stock. MediaAlpha is not offering any shares of Class A common stock in the offering. The Selling Stockholders will receive all of the p...
GAMCO Board Declares Special Dividend of $0.20 per share and Regular Q...
GAMCO Board Declares Special Dividend of $0.20 per share and Regular Quarterly Dividend of $0.04 per share GREENWICH, Conn., May 07, 2024 (GLOBE NEWSWIRE) -- GAMCO Investors, Inc. (“GAMI”) (OTCQX: GAMI) announced today that its Board of Directors approved a special dividend of $0.20 per share and a regular quarterly dividend of $0.04 per share to all of its Class A and Class B shareholders, payable on June 25, 2024 to its shareholders of record on June 11, 2024. About GAMCO Investors, Inc. GAMI is best known for its research-driven value approach to equity investing (known as PMV with a...
Unusual Machines Formalizes CEO’s Contract for Two Years Along with Ot...
Unusual Machines Formalizes CEO’s Contract for Two Years Along with Other Corporate Updates ORLANDO, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Unusual Machines, Inc. (NYSE American: UMAC) (“Unusual Machines” or the “Company”), a drone and drone components manufacturer, today announced it had formalized its contract for Allan Evans to continue to serve as CEO following Unusual Machine’s Board of Directors unanimous approval for two years. The contract follows a rapid series of business developments since Dr. Evans became the CEO less than six months ago. Since his initial appointment, ...
Global Net Lease Reports First Quarter 2024 Results
Global Net Lease Reports First Quarter 2024 Results AFFO Per Share Increased 6% Compared to Fourth Quarter 2023On Target to Reach High End of Disposition Guidance of $600 Million; Currently 7.2% Cash Cap Rate on Occupied DispositionsCompany Reaffirms 2024 Guidance NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Global Net Lease, Inc. (NYSE: GNL) (“GNL” or the “Company”), an internally managed real estate investment trust that focuses on acquiring and managing a globally diversified portfolio of strategically located commercial real estate properties, announced today its financial and operat...
Uniti Group Inc. to Participate at the Goldman Sachs 9th Annual Levera...
Uniti Group Inc. to Participate at the Goldman Sachs 9th Annual Leveraged Finance and Credit Conference LITTLE ROCK, Ark., May 07, 2024 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its President and Chief Executive Officer, Kenny Gunderman, and Vice President, Investor Relations & Treasury, Bill DiTullio, are scheduled to participate at the Goldman Sachs 9th Annual Leveraged Finance and Credit Conference on May 14, 2024 in Rancho Palos Verdes, CA. Any investor materials will be made available on Uniti’s Investor Relations website at under the Events...
Occidental Announces First Quarter 2024 Results
Occidental Announces First Quarter 2024 Results HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- (NYSE: OXY) today announced its first quarter 2024 financial results. The earnings release and accompanying financial schedules can be accessed via the section of the company’s website, . The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call to discuss the results on Wednesday, May 8, 2024, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international call...
Globus Medical Reports First Quarter 2024 Results
Globus Medical Reports First Quarter 2024 Results AUDUBON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2024. Worldwide net sales were $606.7 million, an increase of 119.3%, or 119.8% on a constant currency basisGAAP net loss for the quarter was $7.1 millionGAAP diluted earnings per share (“EPS”) was ($0.05) and non-GAAP diluted EPS was $0.72Non-GAAP adjusted EBITDA was $166.6 million, or 27.5% of net sales “Since the NuVasive merger closed in Se...
CytomX Therapeutics Announces Clinical Collaboration with Merck to Eva...
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab) - CX-801 is a dually masked, conditionally activated IFNα2b cytokine designed using the CytomX Probody® Therapeutic Platform - - Phase 1 first-in-human study expected to start in first half of 2024 - - Clinical trial will evaluate CX-801 as monotherapy and in combination with KEYTRUDA in patients with advanced metastatic solid tumors including melanoma, renal cell carcinoma and head and neck squamous cell carcinoma - SOUTH SAN FRANCISCO, Calif...
Aterian Reports First Quarter 2024 Results
Aterian Reports First Quarter 2024 Results First Quarter Net Loss Improved by 80.0% Year Over Year and Adjusted EBITDA Loss Improved by 38.4% Affirms Second Half 2024 Adjusted EBITDA Profitability Target NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the first quarter ended March 31, 2024. First Quarter Highlights First quarter 2024 net revenue declined 42.0% to $20.2 million, compared to $34.9 million in the first quarter of 2023.First quarter 2024 gross margin improved to 65.1%, compared to 54.8% in ...
Certara Reports First Quarter 2024 Financial Results
Certara Reports First Quarter 2024 Financial Results Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2024. First Quarter Highlights: Revenue was $96.7 million, compared to $90.3 million in the first quarter of 2023, representing growth of 7%. Software revenue was $39.3 million, compared to $33.0 million in the first quarter of 2023, representing growth of 19%.Services revenue was $57.3 million, flat co...
COMPX REPORTS FIRST QUARTER 2024 RESULTS
COMPX REPORTS FIRST QUARTER 2024 RESULTS Dallas, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American: CIX) announced today sales of $38.0 million for the first quarter of 2024 compared to $41.2 million in the same period of 2023. Operating income was $3.7 million in the first quarter of 2024 compared to $7.0 million in the same period of 2023. Net income was $3.7 million, or $.31 per basic and diluted common share, for the first quarter of 2024 compared to $6.1 million, or $.49 per basic and diluted common share, in the same period of 2023. Net sales decreased...
One Liberty Properties Reports First Quarter 2024 Results
One Liberty Properties Reports First Quarter 2024 Results —Closes Acquisition of Industrial Property——Sells Two Assets and Secures Contracts for Three Additional Sales — GREAT NECK, N.Y., May 07, 2024 (GLOBE NEWSWIRE) -- One Liberty Properties, Inc. (the “Company” or “One Liberty”) (NYSE: OLP), a real estate investment trust focused on net leased properties, today announced operating results for the quarter ended March 31, 2024. “We remained focused on the goal of transforming our portfolio towards industrial ownership in the first quarter, working to execute on targeted and opp...
Spectral AI Announces 2024 First Quarter Financial Results
Spectral AI Announces 2024 First Quarter Financial Results Q1 Overview Research & Development Revenue of $6.3 MillionImproved Capital Structure Reflected in Cash of $10.2 MillionDeepView AI®-Burn Devices Deployed in UK; Expect Commercial Revenue in 2H 2024 Additional Regulatory Submissions in US and UK for DeepView™ System Expected in 2024 and 2025 DALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care...
Midland States Bancorp, Inc. Announces Common Stock and Preferred Stoc...
Midland States Bancorp, Inc. Announces Common Stock and Preferred Stock Dividends EFFINGHAM, Ill., May 07, 2024 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that its Board of Directors declared a quarterly cash dividend of $0.31 per share of its common stock. The dividend is payable on May 24, 2024 to all shareholders of record as of the close of business on May 17, 2024. The Board of Directors also declared a cash dividend of $0.4844 per depository share on its 7.75% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A. The dividend will...
Merus gibt Annahme und vorrangige Prüfung des Lizenzantrags für das Bi...
Merus gibt Annahme und vorrangige Prüfung des Lizenzantrags für das Biologikum Zeno zur Behandlung von NRG1+ NSCLC und PDAC durch die US-Zulassungsbehörde FDA bekannt Nach der Zulassung wird Zeno die erste zielgerichtete Therapie für NRG1+ Krebs sein UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, May 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MRUS) (Merus, das Unternehmen, wir oder unser), ein Unternehmen aus dem Bereich der klinischen Onkologie, das innovative multispezifische Antikörper in voller Länge (Biclonics® und Triclonics®) entwickelt, hat heute bekanntgegeben, dass die US-Zula...
Merus annonce l’acceptation par la FDA américaine et l’examen priorita...
Merus annonce l’acceptation par la FDA américaine et l’examen prioritaire de la demande de licence de produit biologique relative à Zeno dans le traitement du CPNPC et de l’ACP NRG1+ S’il est approuvé, Zeno sera le premier traitement ciblé pour le cancer NRG1+ UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 07 mai 2024 (GLOBE NEWSWIRE) -- (Nasdaq : Merus (Merus, la Société, nous ou notre/nos), une société d’oncologie au stade clinique développant des anticorps multispécifiques de pleine longueur innovants (Biclonics® et Triclonics®), a annoncé, ce jour, que la Food and Drug Administrat...
Angi Inc. Earnings Release Available on Company’s Website
Angi Inc. Earnings Release Available on Company’s Website DENVER, May 07, 2024 (GLOBE NEWSWIRE) -- Angi Inc. (NASDAQ: ANGI) posted its first quarter financial results on the investor relations section of its website at . As announced previously, Angi Inc. and IAC will host a conference call to discuss both companies’ respective first quarter results and to answer questions. The call will be held on Wednesday, May 8, 2024, at 8:30 a.m. ET. Joey Levin, CEO of IAC and Chairman of Angi Inc., Jeffrey Kip, CEO of Angi Inc. and Christopher Halpin, Executive Vice President, CFO and COO of IAC, wi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.